StamatakisEAhmadiMNGillJMR, et al.Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. Nat Med. 2022;28(12):2521-2529.
2.
StamatakisEAhmadiMNFriedenreichCM, et al.Vigorous intermittent lifestyle physical activity and cancer incidence among nonexercising adults: the UK biobank accelerometry study. JAMA Oncol. 2023;9(9):1255-1259.
3.
AhmadiMNHamerMGillJMR, et al.Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality in people who do not exercise: a prospective cohort study. Lancet Pub Health. 2023;8(10):e800-e810.
4.
StamatakisEAhmadiMNBiswasRK, et al.Device-measured vigorous intermittent lifestyle physical activity (VILPA) and major adverse cardiovascular events: evidence of sex differences. Br J Sports Med. 2025;59(5):316-324.
5.
KoemelNAAhmadiMNBiswasRK, et al.Device-captured incidental physical activity, sedentary behaviour and all-cause mortality risk. J Epidemiol Community Health. 2025;79(10):753-757.
6.
AhmadiMNHoltermannATudor-LockeC, et al.Time to elicit physiological and exertional vigorous responses from daily living activities: setting foundations of an empirical definition of VILPA. Med Sci Sports Exerc. 2024;56(12):2413-2420.
ReedJLPipeAL. The talk test: a useful tool for prescribing and monitoring exercise intensity. Curr Opin Cardiol. 2014;29(5):475-480.
9.
FranklinBAThompsonPDAl-ZaitiSS, et al.Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective—an update: a scientific statement from the American heart association. Circulation. 2020;141(13):e705-e736.
10.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. 2nd ed.Washington, DC: U.S. Department of Health and Human Services; 2018.
